OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a field of growing interest for tech companies eager to prove AI can pave the ...

April 14 (Reuters) - Amazon's (AMZN.O), opens new tab cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed early-stage drug discovery by ...

Novo Nordisk NOVO.B-4.19%decrease; red down pointing triangle said it would work with ChatGPT maker OpenAI on how to leverage artificial intelligence to discover new drugs, the latest AI partnership ...

OpenAI has announced a strategic partnership with pharma giant Novo Nordisk to use advanced AI for drug discovery, including analyzing complex datasets, identifying drug candidates and reducing the ...

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is hoping to use AI to streamline this process, it announced Tuesday. Amazon ...

When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched carbon structures—points where the molecular chain forks in a specific direction ...

Databricks has outlined a reference architecture for a multi-agent AI system, named AiChemy, that combines internal enterprise data on its platform with external scientific databases via the Model ...

Burmese pythons have pretty irregular eating habits. One of these giant reptiles can swallow an entire antelope whole and then go up to a year and a half without additional meals. Now, scientists have ...

AI-powered biotech company Insilico Medicine has signed a deal with pharma giant Eli Lilly and Company that could be worth $2.75 billion, plus tiered royalties on future sales, that allows the pharma ...

Eli Lilly LLY-0.15%decrease; red down pointing triangle signed a drug discovery deal with InSilico that the Hong Kong-listed company says could be valued at as much as $2.75 billion, as global ...

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Researchers at ...

Indiana Jones’ greatest fear may be obesity’s biggest enemy. Scientists at three universities have turned to nature to find a property that rivals the benefits of GLP-1 drugs without the laundry list ...